November 27, 2014 | Teva Pharmaceutical Industries announced that the board of directors has elected Professor Yitzhak Peterburg as chairman, becoming effective on January 1, 2015. Prof. Peterburg has been a member of the board since 2012 and will replace Dr. Phillip Frost. In addition, the board appointed Dr. Sol J. Barer to the position of director of the board. Prof. Peterburg has previously served as the CEO and president of the Israeli mobile carrier Cellcom from 2003-2005.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments